Literature DB >> 3818233

Computed tomographic staging of gastrointestinal tract malignancies. Part I. Esophagus and stomach.

R A Halvorsen, W M Thompson.   

Abstract

The utility and limitations of CT staging of carcinomas of the esophagus, stomach, small bowel, and colon are reviewed. Routine preoperative staging of esophageal carcinoma is recommended because of CT's sensitivity of more than 90% in detecting mediastinal invasion and a specificity of more than 85% in collected series. We recommend the use of CT as a problem-solving technique rather than as a routine preoperative test in patients with gastroesophageal junction, and gastric and small bowel malignancies. Routine use of CT to stage colorectal carcinomas also does not seem justifiable, due to the inability of CT to determine the depth of bowel wall involvement and to detect tumor in normal size lymph nodes. CT can help differentiate tumors that invade the pelvic side walls from more limited cancers and, therefore, in certain cases can aid in therapy planning. CT is the best method for detecting local recurrence in patients with rectosigmoid carcinomas.

Entities:  

Mesh:

Year:  1987        PMID: 3818233     DOI: 10.1097/00004424-198701000-00001

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  Esophageal squamous cell carcinoma: MRI evaluation of mediastinum.

Authors:  R Petrillo; L Balzarini; P Bidoli; E Ceglia; G D'Ippolito; J D Tess; R Musumeci
Journal:  Gastrointest Radiol       Date:  1990

Review 2.  The red connection: a review of aortic and arterial fistulae with an emphasis on CT findings.

Authors:  Adam Sipe; Sebastian R McWilliams; Lauren Saling; Constantine Raptis; Vincent Mellnick; Sanjeev Bhalla
Journal:  Emerg Radiol       Date:  2016-08-24

Review 3.  Staging of squamous esophageal cancer: accuracy and value.

Authors:  A H Hölscher; H J Dittler; J R Siewert
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

4.  Scintigraphic detection of gastric and pancreatic carcinomas with In-111 ZCE 025 monoclonal antibody.

Authors:  H H Abdel-Nabi; A N Schwartz; D G Wechter; C S Higano; J A Ortman-Nabi; M W Unger
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.